Welcome to our dedicated page for First Trust/abrdn Global Oppos Income news (Ticker: FAM), a resource for investors and traders seeking the latest updates and insights on First Trust/abrdn Global Oppos Income stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect First Trust/abrdn Global Oppos Income's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of First Trust/abrdn Global Oppos Income's position in the market.
Summary not available.
Summary not available.
First Trust Advisors L.P. announced that the ongoing conflict following Russia's invasion of Ukraine is adversely impacting the First Trust/Aberdeen Global Opportunity Income Fund (NYSE: FAM) and the First Trust/Aberdeen Emerging Opportunity Fund (NYSE: FEO). As of March 17, 2022, approximately 1.16% of FAM's managed assets and 1.17% of FEO's managed assets were invested in Russian, Ukrainian, and Belarusian securities, with significant declines in value noted. The conflict and imposed sanctions may further hinder the funds’ ability to manage these investments and affect their net asset value.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.